Axis Securities sees India’s diagnostics sector entering a multi-year growth upcycle, supported by rising demand, scalable models and strong cash generation. It initiated BUY coverage on Dr. Lal PathLabs, Vijaya Diagnostic Centre and Nephrocare Health Services.